XML 47 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net loss $ (13,438,962) $ (4,892,040)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 21,087 10,484
Debt restructuring cost 856,349 139,839
Non-cash interest expense 0 11,846
Loss on litigation settlement 583,601 0
Change in estimated fair value of derivative liabilities 8,547,015 44,705
Loss on debt conversion 40,256 0
Fair market value of equity instruments issued for services 392,093 259,035
Stock based compensation 607,946 765,273
Patent license fees paid with issuance of common stock 0 17,250
Amortization of debt discount and deferred financing costs 5,147 594,358
Changes in operating assets and liabilities:    
Accounts receivable 113,604 191,333
Prepaid expenses (21,097) 1,850
Other assets (8,612) 0
Accounts payable and other current liabilities 46,602 751,210
Due to related parties 116,000 6,000
Net cash used in operating activities (2,138,971) (2,098,857)
Cash flows from investing activities:    
Purchases of property and equipment (96,056) 0
Net cash used in investing activities (96,056) 0
Cash flows from financing activities:    
Principal repayments of notes payable (217,000) (29,610)
Proceeds from the issuance of notes payable 400,000 0
Net proceeds from the issuance of common stock 3,177,032 2,109,834
Net cash provided by financing activities 3,360,032 2,080,224
Net increase (decrease) in cash 1,125,005 (18,633)
Cash at beginning of year 125,274 143,907
Cash at end of year 1,250,279 125,274
Supplemental disclosure of cash flow information    
Interest 13,950 2,821
Income taxes 0 0
Supplement information for non-cash investing and financing activities:    
Conversion of debt, accrued liabilities and accrued interest to common stock 726,776 1,695,059
Reclassification of accounts payable to convertible notes payable 47,000 0
Reclassification of accrued interest to convertible notes payable 20,027 0
Recording deferred financing costs associated with notes payable and convertible notes payable 83,191 7,500
Reclassification of warrant derivative liability into equity 1,456,187 45,081
Issuance of shares under cashless warrant exercises 12,717 0
Exercise of stock option for accrued expenses 13,000 0
Reclassification of note payable to convertible notes payable 0 75,000
Stock issued under restricted stock grant $ 3,400 $ 0